Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin versus aspirin + clopidogrel after transcatheter aortic valve implantation
2014-001675-32Phase 4Active
- Sponsor
- Institut universitaire de cardiologie et de pneumologie de Québec
- Start
- Jul 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin and clopidogrel in aortic valve disease (AVD), myocardial infarction (MI), ischemic stroke and 1 more (2 arms), sponsored by Institut universitaire de cardiologie et de pneumologie de Québec. Primary endpoint: Primary composite endpoint at 3 months. Started Jul 2014; status: active.
02
Drugs
aspirinclopidogrel
03
Conditions
aortic valve disease (AVD)myocardial infarction (MI)ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on 2014-001675-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001675-32.